Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 44.19 | N/A |
| PEG Ratio (TTM) | 13.63 | N/A |
| P/S Ratio (TTM) | 3.98 | N/A |
| P/B Ratio (TTM) | 3.21 | N/A |
| P/FCF Ratio (TTM) | 14.35 | N/A |
| Price to 5YR AVG Earnings Ratio | 55.83 | N/A |
| Price to 5YR AVG FCF Ratio | 61.17 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.18% | N/A |
| ROE (TTM) | 7.09% | N/A |
| Net Profit Margin (TTM) | 9.01% | N/A |
| ROIC 5YR AVG | 9.83% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 9.67% | 2.69% | 22.40% |
| Revenue | -0.76% | 6.68% | 30.92% |
| Net Income | 8.08% | 2.29% | 27.96% |
| Cash Flow | 72.30% | 43.77% | 38.92% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.28 | N/A |
| Quick Ratio (TTM) | 1.17 | N/A |
| D/E Ratio (TTM) | 0.53 | N/A |
| Interest Coverage (TTM) | 3.10 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.34 | N/A |
| LTL to 5YR AVG FCF | 16.18 | N/A |
| Shares Outstanding Growth 5YR AVG | 10.64% | N/A |